Sight Sciences (SGHT)
Develops interventional devices for glaucoma surgery and dry eye treatment.
$8.59
After hours−0.01 (−0.06%)
At close$8.60(+1.24%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$0.13
Revenue estimate
$23.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.23−$0.28−$0.23−$0.16−$0.08−$0.24−$0.08Pending
Estimate−$0.22−$0.29−$0.25−$0.26−$0.15−$0.19−$0.18−$0.13
Surprise−4.5%+3.4%+8.0%+38.5%+46.7%−26.3%+56.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$19.1M$17.5M$19.6M$19.9M$20.4M$19.7M$23.4MPending
Estimate$18.5M$18.5M$17.7M$20.4M$20.3M$18.5M$21.7M$23.6M
Surprise+3.1%−5.3%+10.3%−2.2%+0.2%+6.7%+7.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.04 | — | — |
| Sep 2028 | −$0.01 | — | — |
| Jun 2028 | −$0.02 | — | — |
| Mar 2028 | −$0.02 | — | — |
| Dec 2027 | −$0.14 | — | — |
| Sep 2027 | −$0.16 | — | — |
| Jun 2027 | −$0.16 | — | — |
| Mar 2027 | −$0.17 | — | — |
| Dec 2026 | −$0.16 | — | — |
| Nov 2026 | −$0.13 | — | — |
| Aug 2026 | −$0.18 | −$0.08 | +56.4% |
| May 2026 | −$0.19 | −$0.24 | −26.3% |
| Mar 2026 | −$0.15 | −$0.08 | +46.7% |
| Nov 2025 | −$0.26 | −$0.16 | +38.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.04 | — | — | $30.9M | — | — | — |
| Sep 2028 | −$0.01 | — | — | $27.8M | — | — | — |
| Jun 2028 | −$0.02 | — | — | $28.7M | — | — | — |
| Mar 2028 | −$0.02 | — | — | $24.3M | — | — | — |
| Dec 2027 | −$0.14 | — | — | $25.8M | — | — | — |
| Sep 2027 | −$0.16 | — | — | $26.1M | — | — | — |
| Jun 2027 | −$0.16 | — | — | $26.0M | — | — | — |
| Mar 2027 | −$0.17 | — | — | $21.6M | — | — | — |
| Dec 2026 | −$0.16 | — | — | $23.7M | — | — | — |
| Nov 5, 2026 | −$0.13 | — | — | $23.6M | — | — | — |
| Aug 5, 2026 | −$0.18 | −$0.08 | +56.4% | $21.7M | $23.4M | +7.7% | +27.8% |
| May 6, 2026 | −$0.19 | −$0.24 | −26.3% | $18.5M | $19.7M | +6.7% | +23.0% |
| Mar 4, 2026 | −$0.15 | −$0.08 | +46.7% | $20.3M | $20.4M | +0.2% | −26.8% |
| Nov 6, 2025 | −$0.26 | −$0.16 | +38.5% | $20.4M | $19.9M | −2.2% | +16.4% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 5, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 2, 2024 | |||||||
| Mar 7, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 13, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| Jul 15, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |